179 related articles for article (PubMed ID: 21418334)
1. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
[TBL] [Abstract][Full Text] [Related]
2. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
4. [Circulating VEGF and its soluble receptor sVEGFR-1 in patients with lung cancer].
Swidzińska E; Ossolińska M; Naumnik W; Izycki T; Kucejko W; Chyczewska E
Pneumonol Alergol Pol; 2004; 72(9-10):389-94. PubMed ID: 16021992
[TBL] [Abstract][Full Text] [Related]
5. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease.
Kierszniewska-Stepień D; Pietras T; Górski P; Stepien H
Eur Cytokine Netw; 2006 Mar; 17(1):75-9. PubMed ID: 16613766
[TBL] [Abstract][Full Text] [Related]
7. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
Pietrowski D; Szabo L; Sator M; Just A; Egarter C
Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
[TBL] [Abstract][Full Text] [Related]
9. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
10. Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
Svendsen MN; Werther K; Christensen IJ; Basse L; Nielsen HJ
Inflamm Res; 2005 Nov; 54(11):458-63. PubMed ID: 16307219
[TBL] [Abstract][Full Text] [Related]
11. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
12. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
[TBL] [Abstract][Full Text] [Related]
13. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
14. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I; Myśliwiec H; Chodynicka B
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
[TBL] [Abstract][Full Text] [Related]
15. [Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment].
Serwin AB; Sokołowska M; Chodynicka B
Przegl Lek; 2005; 62(2):95-7. PubMed ID: 16095152
[TBL] [Abstract][Full Text] [Related]
16. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
Serwin AB; Wasowicz W; Chodynicka B
Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
[TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
19. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
20. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
